Additionally, YTHDF2 is recognized as an oncogene that is upregulated in lung cancer and acute myeloid leukemia (AML) to promote tumor initiation and growth, exhibiting a completely opposite function as in HCC (60, 61). The gene discussed is YTHDF2; the disease is acute myeloid leukemia.